Infectious Vaccines Market Report

Global and China Infectious Vaccines Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 02, 2022
  • PAGES：147
  • REPORT CODE：GMM1338887
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.

    Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.

    This report elaborates on the current development of the Infectious Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Novartis AG (Switzerland)

    • MedImmune LLC (US)

    • CSL Limited (Australia)

    • Johnson and Johnson (US)

    • Merck and Company (US)

    • Emergent Bio Solutions Inc (US)

    • GlaxoSmithKline plc (UK)

    • Bavarian Nordic (Denmark)

    • Sanofi Pasteur (France)

    • Pfizer Inc (US)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Preventive vaccine

    • Therapeutic vaccine

    Application:

    • Adults

    • Pediatrics

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Infectious Vaccines Industry Overview

      • 1.1.1 Infectious Vaccines Market Scope and Market Segments

      • 1.1.2 Infectious Vaccines Industry Characteristics

      • 1.1.3 Global and China Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Infectious Vaccines Production Value and Growth Rate (2017-2028)

    • 1.2 Global Infectious Vaccines Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Preventive vaccine

      • 1.2.2 Therapeutic vaccine

    • 1.3 Global Infectious Vaccines Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Adults

      • 1.3.2 Pediatrics

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Infectious Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Infectious Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Infectious Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Infectious Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Infectious Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Infectious Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Infectious Vaccines Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Infectious Vaccines Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Infectious Vaccines Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Infectious Vaccines Industry Porter's Five Forces Model Analysis

      • 2.2.3 Infectious Vaccines Industry PEST Analysis

    • 2.3 Infectious Vaccines Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Infectious Vaccines Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Infectious Vaccines Industry

    Chapter 3 Global and China Infectious Vaccines Market, by Manufacturer

    • 3.1 Global and China Infectious Vaccines Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Infectious Vaccines Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Infectious Vaccines Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Infectious Vaccines Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Infectious Vaccines Market Top 3 Players

    Chapter 4 Global and China Infectious Vaccines Market, by Type (2017-2028)

    • 4.1 Infectious Vaccines Market Trend, by Type

    • 4.2 Global Infectious Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Infectious Vaccines Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Infectious Vaccines Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Infectious Vaccines Price Trend, by Type (2017-2028)

    • 4.3 China Infectious Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Infectious Vaccines Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Infectious Vaccines Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Infectious Vaccines Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Infectious Vaccines Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Infectious Vaccines Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Infectious Vaccines Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Infectious Vaccines Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Infectious Vaccines Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Infectious Vaccines Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Infectious Vaccines Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Infectious Vaccines Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Infectious Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Infectious Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Infectious Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Infectious Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Infectious Vaccines Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Infectious Vaccines Market Analysis

    • 7.1 North America Infectious Vaccines Market, by Type

    • 7.2 North America Infectious Vaccines Market, by Application

    • 7.3 North America Infectious Vaccines Market Analysis and Forecast, by Country

      • 7.3.1 United States Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Infectious Vaccines Market Analysis

    • 8.1 Europe Infectious Vaccines Market, by Type

    • 8.2 Europe Infectious Vaccines Market, by Application

    • 8.3 Europe Infectious Vaccines Market Analysis and Forecast, by Country

      • 8.3.1 Germany Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Infectious Vaccines Market Analysis

    • 9.1 APAC Infectious Vaccines Market, by Type

    • 9.2 APAC Infectious Vaccines Market, by Application

    • 9.3 APAC Infectious Vaccines Market Analysis and Forecast, by Country

      • 9.3.1 China Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Infectious Vaccines Market Analysis

    • 10.1 Latin America, Middle East and Africa Infectious Vaccines Market, by Type

    • 10.2 Latin America, Middle East and Africa Infectious Vaccines Market, by Application

    • 10.3 Latin America, Middle East and Africa Infectious Vaccines Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Infectious Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Infectious Vaccines Company Profiles

      • 11.1 Novartis AG (Switzerland)

        • 11.1.1 Novartis AG (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Novartis AG (Switzerland) Infectious Vaccines Product Profiles, Application and Specification

        • 11.1.3 Novartis AG (Switzerland) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 MedImmune LLC (US)

        • 11.2.1 MedImmune LLC (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 MedImmune LLC (US) Infectious Vaccines Product Profiles, Application and Specification

        • 11.2.3 MedImmune LLC (US) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 CSL Limited (Australia)

        • 11.3.1 CSL Limited (Australia) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 CSL Limited (Australia) Infectious Vaccines Product Profiles, Application and Specification

        • 11.3.3 CSL Limited (Australia) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Johnson and Johnson (US)

        • 11.4.1 Johnson and Johnson (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Johnson and Johnson (US) Infectious Vaccines Product Profiles, Application and Specification

        • 11.4.3 Johnson and Johnson (US) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Merck and Company (US)

        • 11.5.1 Merck and Company (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Merck and Company (US) Infectious Vaccines Product Profiles, Application and Specification

        • 11.5.3 Merck and Company (US) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Emergent Bio Solutions Inc (US)

        • 11.6.1 Emergent Bio Solutions Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Emergent Bio Solutions Inc (US) Infectious Vaccines Product Profiles, Application and Specification

        • 11.6.3 Emergent Bio Solutions Inc (US) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 GlaxoSmithKline plc (UK)

        • 11.7.1 GlaxoSmithKline plc (UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 GlaxoSmithKline plc (UK) Infectious Vaccines Product Profiles, Application and Specification

        • 11.7.3 GlaxoSmithKline plc (UK) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Bavarian Nordic (Denmark)

        • 11.8.1 Bavarian Nordic (Denmark) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Bavarian Nordic (Denmark) Infectious Vaccines Product Profiles, Application and Specification

        • 11.8.3 Bavarian Nordic (Denmark) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Sanofi Pasteur (France)

        • 11.9.1 Sanofi Pasteur (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Sanofi Pasteur (France) Infectious Vaccines Product Profiles, Application and Specification

        • 11.9.3 Sanofi Pasteur (France) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Pfizer Inc (US)

        • 11.10.1 Pfizer Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Pfizer Inc (US) Infectious Vaccines Product Profiles, Application and Specification

        • 11.10.3 Pfizer Inc (US) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Infectious Vaccines Industry Investment Prospect and Risk Assessment

    • 12.1 Infectious Vaccines Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Infectious Vaccines Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure China Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Global Infectious Vaccines Production Value and Growth Rate (2017-2028)

    • Figure China Infectious Vaccines Production Value and Growth Rate (2017-2028)

    • Figure Global Infectious Vaccines Market Size and Growth Rate of Preventive vaccine (2017-2028)

    • Figure Global Infectious Vaccines Market Size and Growth Rate of Therapeutic vaccine (2017-2028)

    • Figure Global Infectious Vaccines Market Size and Growth Rate of Adults (2017-2028)

    • Figure Global Infectious Vaccines Market Size and Growth Rate of Pediatrics (2017-2028)

    • Figure North America Infectious Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Infectious Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Infectious Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Infectious Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Infectious Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Infectious Vaccines Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Infectious Vaccines Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Infectious Vaccines Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Infectious Vaccines Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Infectious Vaccines Market Share, by Manufacturer in 2021

    • Figure Global and China Infectious Vaccines Market Share, by Manufacturer in 2022

    • Table Global Infectious Vaccines Sales Volume, by Type (2017-2028)

    • Table Global Infectious Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Global Infectious Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Global Infectious Vaccines Sales Value, by Type (2017-2028)

    • Table Global Infectious Vaccines Sales Value Share, by Type (2017-2028)

    • Figure Global Infectious Vaccines Price Trend, by Type (2017-2028)

    • Table China Infectious Vaccines Sales Volume, by Type (2017-2028)

    • Table China Infectious Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure China Infectious Vaccines Sales Volume Share, by Type (2017-2028)

    • Table China Infectious Vaccines Sales Value, by Type (2017-2028)

    • Table China Infectious Vaccines Sales Value Share, by Type (2017-2028)

    • Figure China Infectious Vaccines Price Trend, by Type (2017-2028)

    • Table Global Infectious Vaccines Sales Volume, by Application (2017-2028)

    • Table Global Infectious Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Global Infectious Vaccines Sales Volume Share, by Application (2017-2028)

    • Table Global Infectious Vaccines Sales Value, by Application (2017-2028)

    • Table Global Infectious Vaccines Sales Value Share, by Application (2017-2028)

    • Figure Global Infectious Vaccines Sales Value Share, by Application (2017-2028)

    • Table China Infectious Vaccines Sales Volume, by Application (2017-2028)

    • Table China Infectious Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure China Infectious Vaccines Sales Volume Share, by Application (2017-2028)

    • Table China Infectious Vaccines Sales Value, by Application (2017-2028)

    • Table China Infectious Vaccines Sales Value Share, by Application (2017-2028)

    • Figure China Infectious Vaccines Sales Value Share, by Application (2017-2028)

    • Figure China Infectious Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure North America Infectious Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Infectious Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Infectious Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Infectious Vaccines Production, Import, Consumption and Export (2017-2022)

    • Table North America Infectious Vaccines Sales Volume, by Type (2017-2028)

    • Table North America Infectious Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure North America Infectious Vaccines Sales Volume Share, by Type (2017-2028)

    • Table North America Infectious Vaccines Sales Volume, by Application (2017-2028)

    • Table North America Infectious Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure North America Infectious Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure United States Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure United States Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Canada Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Europe Infectious Vaccines Sales Volume, by Type (2017-2028)

    • Table Europe Infectious Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Europe Infectious Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Europe Infectious Vaccines Sales Volume, by Application (2017-2028)

    • Table Europe Infectious Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Europe Infectious Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Germany Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure UK Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure UK Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure France Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure France Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Italy Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Spain Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Poland Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Russia Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Table APAC Infectious Vaccines Sales Volume, by Type (2017-2028)

    • Table APAC Infectious Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure APAC Infectious Vaccines Sales Volume Share, by Type (2017-2028)

    • Table APAC Infectious Vaccines Sales Volume, by Application (2017-2028)

    • Table APAC Infectious Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure APAC Infectious Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure China Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure China Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Japan Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure India Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure India Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Infectious Vaccines Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Infectious Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Infectious Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Infectious Vaccines Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Infectious Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Infectious Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Infectious Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Infectious Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Novartis AG (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG (Switzerland) Product Profiles, Application and Specification

    • Table Novartis AG (Switzerland) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table MedImmune LLC (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table MedImmune LLC (US) Product Profiles, Application and Specification

    • Table MedImmune LLC (US) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CSL Limited (Australia) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CSL Limited (Australia) Product Profiles, Application and Specification

    • Table CSL Limited (Australia) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson and Johnson (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson and Johnson (US) Product Profiles, Application and Specification

    • Table Johnson and Johnson (US) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck and Company (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck and Company (US) Product Profiles, Application and Specification

    • Table Merck and Company (US) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Emergent Bio Solutions Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Emergent Bio Solutions Inc (US) Product Profiles, Application and Specification

    • Table Emergent Bio Solutions Inc (US) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline plc (UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline plc (UK) Product Profiles, Application and Specification

    • Table GlaxoSmithKline plc (UK) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bavarian Nordic (Denmark) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bavarian Nordic (Denmark) Product Profiles, Application and Specification

    • Table Bavarian Nordic (Denmark) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Pasteur (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Pasteur (France) Product Profiles, Application and Specification

    • Table Sanofi Pasteur (France) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Inc (US) Product Profiles, Application and Specification

    • Table Pfizer Inc (US) Infectious Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US